[Summary] FY2026 Medical Fee Revision – Radical Reform Needed for Regional Hospital Management – Medical Tribune

News Highlights

The FY2026 medical fee revision will compel regional hospitals to undertake fundamental management reforms. In particular, the importance of mid- to long-term management and succession strategies will increase, including maintaining facility standards, distributing the burden of capital investment, and utilizing tax benefits by transitioning to specific medical corporations or social medical corporations. Planning that considers the medical fee revision cycle is essential.

M&A Medical Editorial Department’s Perspective

The summary of the FY2026 medical fee revision signals an urgent need for regional hospitals to act. The core of the revision is not merely a change in fee points, but a response to more structural issues such as the differentiation and collaboration of medical functions, and the strengthening of management foundations. Especially for maintaining and enhancing facility standards, it is likely that cases where capital investment and personnel recruitment become difficult for medical institutions below a certain scale will increase. This suggests that for regional hospitals finding it difficult to survive independently, M&A to gain economies of scale or sharing management resources through group corporatization can be realistic options for business continuity. Furthermore, early consideration of utilizing tax schemes with a view to transitioning to social medical corporations or specific medical corporations will be indispensable. This revision is seen as an opportunity to promote fundamental business succession and organizational restructuring to build a sustainable management base while maintaining the quality of regional healthcare.

Points Raised by This News

• For regional hospitals, formulating mid- to long-term management and succession strategies that consider the revision cycle is an urgent issue.
• Pursuing economies of scale through group participation is increasingly important for maintaining facility standards and reducing the burden of capital investment.
• Utilizing tax schemes, including transitioning to specific medical corporations and social medical corporations, holds the key to strengthening management foundations.
• The current revision is structured to encourage M&A and organizational restructuring for regional hospitals that find it difficult to survive independently.

Practical Questions Arising from This News

• What impact will this medical fee revision have on maintaining our hospital’s facility standards?
• What are specific examples of tax benefits and improved management efficiency through group corporatization?
• When considering M&A, what timing and schemes are most optimal?

If You Feel “Should I Consult?”

Medical institution managers and successors who are concerned about the impact of the FY2026 medical fee revision on their hospital’s management, or who are interested in strengthening management through economies of scale and tax schemes, should consult with an expert. This is particularly true as we enter a phase where mid- to long-term management strategy and business succession are considered as an integrated whole, and early consultation is key to expanding future options.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics with a complete success fee basis. Consultations are accepted with strict confidentiality. Free consultation here